United Therapeutics Net Income 2006-2019 | UTHR

United Therapeutics net income from 2006 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
United Therapeutics Annual Net Income
(Millions of US $)
2018 $589
2017 $418
2016 $714
2015 $652
2014 $340
2013 $175
2012 $304
2011 $218
2010 $106
2009 $19
2008 $-49
2007 $12
2006 $74
2005 $65
United Therapeutics Quarterly Net Income
(Millions of US $)
Q2 2019 $205
Q1 2019 $-495
Q4 2018 $65
Q3 2018 $107
Q2 2018 $173
Q1 2018 $245
Q4 2017 $19
Q3 2017 $276
Q2 2017 $-56
Q1 2017 $179
Q4 2016 $110
Q3 2016 $162
Q2 2016 $206
Q1 2016 $236
Q4 2015 $105
Q3 2015 $464
Q2 2015 $99
Q1 2015 $-17
Q4 2014 $116
Q3 2014 $-25
Q2 2014 $112
Q1 2014 $138
Q4 2013 $-30
Q3 2013 $63
Q2 2013 $80
Q1 2013 $62
Q4 2012 $83
Q3 2012 $78
Q2 2012 $72
Q1 2012 $71
Q4 2011 $43
Q3 2011 $84
Q2 2011 $74
Q1 2011 $16
Q4 2010 $10
Q3 2010 $40
Q2 2010 $38
Q1 2010 $19
Q4 2009 $-3
Q3 2009 $12
Q2 2009 $-2
Q1 2009 $13
Q4 2008 $-82
Q3 2008 $11
Q2 2008 $12
Q1 2008 $10
Q4 2007 $-6
Q3 2007 $15
Q2 2007 $6
Q1 2007 $-3
Q4 2006 $56
Q3 2006 $8
Q2 2006 $8
Q1 2006 $2
Q4 2005 $29
Q3 2005 $16
Q2 2005 $12
Q1 2005 $8
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $3.541B $1.628B
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. United Therapeutics (UT) has an overarching commitment to environmental sustainability. The company's product candidates include Adcirca is a phosphodiesterase 5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH)(WHO Group 1) to improve exercise ability in PAH patients. Orenitram is a prostacyclin vasodilator indicated for treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. Remodulin is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated with exercise. Tyvaso is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $60.846B 37.47
Takeda Pharmaceutical (TAK) Japan $53.241B 8.33
Astellas Pharma (ALPMY) Japan $28.433B 13.55
Merck (MKGAF) Germany $14.488B 19.77
Eisai (ESALY) Japan $14.130B 21.63
UCB SA (UCBJF) Belgium $13.839B 0.00
Grifols, S.A (GRFS) Spain $13.744B 17.53
Ono Pharmaceutical (OPHLF) Japan $9.212B 19.69
Ionis Pharmaceuticals (IONS) United States $8.725B 18.82
Neurocrine Biosciences (NBIX) United States $8.110B 0.00
IPSEN SA ADR (IPSEY) France $7.776B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 0.00
Sage Therapeutics (SAGE) United States $7.024B 0.00
Catalent (CTLT) United States $6.972B 27.56
Jazz Pharmaceuticals (JAZZ) Ireland $6.679B 8.79
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.026B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $5.083B 18.27
FibroGen (FGEN) United States $3.185B 79.67
Evotec AG (EVTCY) Germany $3.183B 43.58
Arrowhead Pharmaceuticals (ARWR) United States $3.034B 69.57
Taro Pharmaceutical Industries (TARO) Israel $2.869B 10.28
Nektar Therapeutics (NKTR) United States $2.827B 0.00
PTC Therapeutics (PTCT) United States $2.116B 0.00
Tilray (TLRY) Canada $2.016B 0.00
Xencor (XNCR) United States $1.925B 41.97
Portola Pharmaceuticals (PTLA) United States $1.793B 0.00
Zogenix (ZGNX) United States $1.779B 0.00
Corcept Therapeutics (CORT) United States $1.587B 21.81
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
USANA Health Sciences (USNA) United States $1.543B 15.48
Pacira Pharmaceuticals (PCRX) United States $1.531B 55.71
Heron Therapeutics (HRTX) United States $1.413B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.341B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.147B 18.92
Radius Health (RDUS) United States $1.123B 0.00
ArQule (ARQL) United States $1.050B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.008B 0.00
TherapeuticsMD (TXMD) United States $0.931B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.864B 3.85
Spectrum Pharmaceuticals (SPPI) United States $0.820B 0.00
Aerie Pharmaceuticals (AERI) United States $0.814B 0.00
Dova Pharmaceuticals (DOVA) United States $0.813B 0.00
Endo (ENDP) Ireland $0.810B 1.43
Organogenesis Holdings (ORGO) United States $0.676B 0.00
Karyopharm Therapeutics (KPTI) United States $0.619B 0.00
Concordia (CXRXF) Canada $0.615B 0.00
Flexion Therapeutics (FLXN) United States $0.505B 0.00
Akebia Therapeutics (AKBA) United States $0.492B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.478B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.470B 0.00
Translate Bio (TBIO) United States $0.457B 0.00
ChemoCentryx (CCXI) United States $0.448B 0.00
Lannett Co Inc (LCI) United States $0.448B 4.72
Siga Technologies (SIGA) United States $0.447B 1.04
Indivior (INVVY) United States $0.444B 1.61
Innate Pharma SA (IPHYF) France $0.410B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.400B 0.00
Collegium Pharmaceutical (COLL) United States $0.398B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.396B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.373B 16.98
ImmunoGen (IMGN) United States $0.351B 0.00
DURECT (DRRX) United States $0.342B 0.00
Harpoon Therapeutics (HARP) United States $0.339B 0.00
Dermira (DERM) United States $0.298B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.298B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.278B 0.00
Ardelyx (ARDX) United States $0.268B 0.00
OptiNose (OPTN) United States $0.266B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.265B 0.00
Molecular Templates (MTEM) United States $0.253B 0.00
Recro Pharma (REPH) United States $0.249B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.230B 0.00
Xeris Pharmaceuticals (XERS) United States $0.208B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.200B 0.00
CV Sciences (CVSI) United States $0.194B 0.00
KalVista Pharmaceuticals (KALV) United States $0.192B 0.00
GlycoMimetics (GLYC) United States $0.189B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.179B 0.00
Nature's Sunshine Products (NATR) United States $0.170B 28.39
AcelRx Pharmaceuticals (ACRX) United States $0.168B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.145B 0.00
Redhill Biopharma (RDHL) Israel $0.143B 0.00
Concert Pharmaceuticals (CNCE) United States $0.139B 0.00
Calithera Biosciences (CALA) United States $0.138B 0.00
IMV INC (IMV) Canada $0.133B 0.00
Ocular Therapeutix (OCUL) United States $0.132B 0.00
Generex Biotechnology (GNBT) United States $0.131B 0.00
CannTrust Holdings (CTST) Canada $0.127B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.125B 0.00
MEI Pharma (MEIP) United States $0.118B 0.00
Jounce Therapeutics (JNCE) United States $0.108B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Cardiome Pharma (CORV) Canada $0.088B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 33.35
MediWound (MDWD) Israel $0.081B 0.00
Aquestive Therapeutics (AQST) United States $0.079B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.079B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.077B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.076B 0.00
Majesco Entertainment (PTE) United States $0.073B 0.00
Neos Therapeutics (NEOS) United States $0.073B 0.00
ElectroCore (ECOR) United States $0.072B 0.00
Lipocine (LPCN) United States $0.068B 0.00
Natural Alternatives (NAII) United States $0.068B 10.16
Otonomy (OTIC) United States $0.066B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
RENEURON GP (RNUGF) United Kingdom $0.065B 0.00
Genocea Biosciences (GNCA) United States $0.063B 0.00
Iterum Therapeutics (ITRM) Ireland $0.063B 0.00
Infinity Pharmaceuticals (INFI) United States $0.062B 0.00
IntelGenx Technologies (IGXT) Canada $0.062B 0.00
Novan (NOVN) United States $0.061B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.058B 0.00
SCYNEXIS (SCYX) United States $0.056B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.056B 1.94
Pharmaxis (PXSLY) Australia $0.055B 0.00
Capnia (SLNO) United States $0.053B 0.00
Melinta Therapeutics (MLNT) United States $0.052B 0.00
Nivalis Therapeutics (ALPN) United States $0.050B 0.00
Aclaris Therapeutics (ACRS) United States $0.049B 0.00
Forward Pharma (FWP) Denmark $0.045B 0.00
CTI BioPharma (CTIC) United States $0.043B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.042B 0.00
Mannatechorporated (MTEX) United States $0.041B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.039B 0.00
Mast Therapeutics (SVRA) United States $0.037B 0.00
Jaguar Animal Health (JAGX) United States $0.035B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.033B 0.00
Opexa Therapeutics (ACER) United States $0.029B 0.00
PharmAthene (ALT) United States $0.029B 0.00
Biomerica (BMRA) United States $0.029B 0.00
Bio-Path Holdings (BPTH) United States $0.027B 0.00
China SXT Pharmaceuticals (SXTC) China $0.026B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Heat Biologics (HTBX) United States $0.014B 0.00
Vical (BBI) United States $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Achieve Life Sciences (ACHV) United States $0.013B 0.00
HANCOCK JAFFE (HJLI) United States $0.013B 0.00
Shineco (TYHT) China $0.012B 17.67
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Onconova Therapeutics (ONTX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00